[00:09:40] Dr Chris Morrissey: No for sure
What This Means for Patients Using GLP-1s GLP-1 receptor agonists remain among the most effective treatments for weight loss and type 2 diabetes, and for most patients, the benefits far outweigh the risks
Your dosing, duration, and monitoring are personalized based on your goals and health history
Unlike the other pathways, NRH and NMNH are condensed into NADH, possibly by NMNAT 35
Nausea and reduced appetite from semaglutide usually diminish within 48 weeks
In a Phase II trial (NCT01398748) on PD, intranasal GSH at doses of 300 mg/day and 600 mg/day showed nonsignificant trends toward motor improvement, with slight reductions in total and motor Unified Parkinsons Disease Rating Scale (UPDRS) scores compared to placebo (total UPDRS: 5.3 and 4.3 vs